MetaCap

Who Owns Aurinia Pharmaceuticals Stock?

NASDAQ: AUPHHealth CareBiotechnology: Pharmaceutical PreparationsUSD

14.70-0.19 (-1.28%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Ownership breakdown

Held by institutions
60.12%
Institutional holders
378
  • Institutions 60.1%
  • Insiders 6.7%
  • Public and other 33.1%

Who owns Aurinia Pharmaceuticals stock?

Institutional investors own about 60.1% of Aurinia Pharmaceuticals's shares, spread across 378 institutions that file 13F reports. That level of institutional ownership is moderate. Insiders, including executives, directors and large founding shareholders, hold 6.74% of AUPH.

The largest institutional holders are Tang Capital Management, LLC (9.73%), Blackrock Inc. (6.41%) and Goldman Sachs Group Inc (4.73%). Together, the top 10 institutions control 34.3% of shares outstanding. In their latest filings, 4 of the top 10 institutions increased their AUPH positions and 4 reduced them.

Summary generated from market data by MetaCap's automated system. Methodology

Top institutional holders of AUPH

Aurinia Pharmaceuticals top institutional holders
InstitutionShares% HeldChange
Tang Capital Management, LLC13.04M9.73%0.0%
Blackrock Inc.8.59M6.41%+4.8%
Goldman Sachs Group Inc6.34M4.73%+12.8%
NEA Management Company, LLC3.97M2.96%0.0%
Arrowstreet Capital, Limited Partnership2.98M2.23%-8.6%
Two Sigma Investments, LP2.95M2.20%-14.8%
State Street Corporation2.59M1.93%+0.1%
Marshall Wace LLP1.90M1.42%-7.2%
LSV Asset Management1.81M1.35%+67.5%
Morgan Stanley1.79M1.34%-22.4%

% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.

Top mutual fund and ETF holders of AUPH

Aurinia Pharmaceuticals top fund holders
FundShares% Held
iShares Trust-iShares Russell 2000 ETF3.09M2.31%
Fidelity Salem Street Trust-Fidelity Small Cap Index Fund1.31M0.97%
iShares Trust-iShares Russell 2000 Growth ETF1.12M0.83%
iShares Trust-iShares Biotechnology ETF917.68K0.68%
VANGUARD SCOTTSDALE FUNDS-Vanguard Russell 2000 Index Fund683.82K0.51%
Goldman Sachs Trust-Goldman Sachs U.S. Tax-Managed Equity Fund541.44K0.40%
TIAA-CREF Funds-Nuveen Quant Small Cap Equity Fund480.65K0.36%
Fidelity Commonwealth Trust II-Fidelity Enhanced Small Cap Core ETF456.49K0.34%
Goldman Sachs Trust-Goldman Sachs Small Cap Value Insights Fund334.69K0.25%
VANGUARD WORLD FUND-Vanguard Health Care Index Fund323.93K0.24%

Frequently asked questions

Who is the largest shareholder of Aurinia Pharmaceuticals?

Tang Capital Management, LLC is the largest institutional shareholder of AUPH, owning 9.73% of shares outstanding (13.04M shares) as of its latest 13F filing.

What percentage of Aurinia Pharmaceuticals is owned by institutions?

Institutions own about 60.1% of AUPH shares and 64.5% of the public float.

How much of Aurinia Pharmaceuticals do insiders own?

Insiders, such as officers and directors, own about 6.74% of AUPH shares outstanding.

Where does institutional ownership data come from?

Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.

Related